Skip to content

Pharminent

cropped-ChatGPT-Image-May-20-2026-08_10_54-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Gilead inks $140M API supply deal, tightening ties to Korean manufacturer
  • M&A / Deals

Gilead inks $140M API supply deal, tightening ties to Korean manufacturer

BioSpace

The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea's Yuhan.

Read full story

pharminent May 22, 2026 (Last updated: May 22, 2026)

BioSpace

The agreement is the largest in a series of deals that Gilead Sciences has penned with Korea’s Yuhan.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: GBL joins CVC in 10.7bn takeover bid for Recordati
Next: Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival

Related Stories

  • M&A / Deals

GBL joins CVC in 10.7bn takeover bid for Recordati

pharminent May 22, 2026
  • M&A / Deals

Gilead Sciences completes Tubulis acquisition for $5bn

pharminent May 22, 2026
  • M&A / Deals

Lilly, BMS, Incyte strike deals to keep biopharma’s AI integration rolling

pharminent May 21, 2026

You May Have Missed

  • Clinical Data

Parkinson’s drug from Biogen, Denali comes up short

pharminent May 22, 2026
  • Clinical Data

Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival

pharminent May 22, 2026
  • M&A / Deals

Gilead inks $140M API supply deal, tightening ties to Korean manufacturer

pharminent May 22, 2026
  • M&A / Deals

GBL joins CVC in 10.7bn takeover bid for Recordati

pharminent May 22, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.